Charles River Laboratories International Aktie
WKN: 939391 / ISIN: US1598641074
|
05.11.2025 14:29:05
|
Charles River Laboratories Updates FY25 Earnings Outlook
(RTTNews) - Charles River Laboratories International, Inc. (CRL), Wednesday an updated financial outlook for fiscal year 2025.
The company now anticipates earnings of $4.15 - $4.35 per share, instead of previously estimated $4.25 - $4.65 per share.
Meanwhile, it projects adjusted earnings of $10.10 - $10.30 per share instead of previously announced $9.90 - $10.30 per share.
On average, analysts estimate earnings of $10.19 per share for the quarter.
In the pre-market hours, CRL is trading at $173, down 2.73 percent on the New York Stock Exchange.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Charles River Laboratories International Inc.mehr Nachrichten
Analysen zu Charles River Laboratories International Inc.mehr Analysen
Aktien in diesem Artikel
| Charles River Laboratories International Inc. | 147,70 | 0,24% |
|